AwardedPOLGoods
Dostawa produktu leczniczego zawierającego substancję czynną Mirvetuximabum soravtansinum
- Published
- Published 9 July 2026
Overview
Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie has procured the supply of 300 packages of a pharmaceutical product containing the active substance Mirvetuximabum soravtansinum. The contract was awarded to Abbvie Sp. z o.o. on 8 July 2026 for a value of 3,779,997.84 PLN.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Published
- 9 July 2026
Pharmaceutical products
Award outcome
- Awarded value
- PLN 3,779,998
- Award date
- 8 July 2026
- Contract period
- — → 3 July 2027
- Abbvie Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
9 July 2026
Contracting authority
Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie
Procuring entityLublin, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.